Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22856783 | 1.00 | PTGS1 (0.33) | PTGS1 | |
| SCHEMBL23740691 | 0.71 | CYP1A2 (0.33) | PTGS1 | |
| SCHEMBL23740692 | 0.70 | PTGS1 (0.40) | PTGS1 | |
| SCHEMBL23740751 | 0.69 | CYP1A2 (0.32) | PTGS1 | |
| SCHEMBL23740693 | 0.69 | CYP1A2 (0.32) | PTGS1 | |
| SCHEMBL23740684 | 0.69 | CYP1A2 (0.32) | PTGS1 | |
| SCHEMBL1786829 | 0.69 | APLNR (0.46) | PTGS1 | |
| SCHEMBL25971336 | 0.69 | APLNR (0.46) | PTGS1 | |
| SCHEMBL17414390 | 0.69 | APLNR (0.46) | PTGS1 | |
| SCHEMBL715584 | 0.66 | APLNR (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10883066-B2 | Vetiver odorant | FIRMENICH SA (CH) | 2021-01-05 | — | — | US | disclosed |
| US-20200109348-A1 | VETIVER ODORANT | FIRMENICH SA (CH) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10883066-B2 | Vetiver odorant | VIPR1, VIPR2, BLVRB | PTGS1 1374/4885 |
| US-20200109348-A1 | VETIVER ODORANT | VIPR1, VIPR2, BLVRB | PTGS1 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.